TrialAmerican journal of respiratory and critical care medicine2022

A Phase 3, Open-Label Study of Lumacaftor/Ivacaftor in Children 1 to Less Than 2 Years of Age with Cystic Fibrosis Homozygous for

Jonathan H Rayment et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.